Commensal-derived Trehalose Monocorynomycolate Triggers γδ T Cell-driven Protective Ocular Barrier Immunity

Authors:

Abstract
SUMMARY: Commensals shape host physiology through molecular crosstalk with host receptors. Identifying specific microbial factors that causally influence host immunity is key to understanding homeostasis at the host-microbe interface and advancing microbial-based therapeutics. Here, we identify trehalose monocorynomycolate (TMCM) from Corynebacterium mastitidis ( C. mast ) as a potent stimulator of IL-17 production by γδ T cells at the ocular surface. Mechanistically, TMCM-driven IL-17 responses require both IL-1 signals and γδ TCR signaling, which also supports endogenous γδ T cell IL-1R1 expression. Notably, synthetic TMCM alone is sufficient to mimic the effect of C. mast in inducing γδ T cell immunity and protect against pathogenic corneal infection. Our findings establish TMCM as a key mediator of commensal-driven immune defense, highlighting its potential as a γδ T cell adjuvant and a microbiome-informed therapeutic to enhance IL-17-driven protection at barrier sites such as the ocular surface. Graphical HIGHLIGHTS: Corynomycolates enable ocular C. mast colonization and protective IL-17 immunity TMCM drives IL-17 from γδ T cells through TCR and IL-1R signaling γδ TCR signaling maintains the expression of endogenous IL-1R1 Synthetic TMCM mimics the ability of C. mast to induce γδ T cell immunity in the eye TMCM protects against P. aeruginosa keratitis, highlighting its therapeutic potential
All Related Versions

This publication has 38 references indexed in Scilit: